Abeona Therapeutics Inc. Common Stock (NASDAQ: ABEO) last traded at $6.09, up 2.18% on the session. The quote above updates while this page is open; the figures below are drawn from Abeona Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Abeona Therapeutics Inc. Common Stock trades on NASDAQ under the ticker ABEO. Its market capitalisation is $348.25 million.
Valuation measures for Abeona Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $348.25M |
|---|---|
| Enterprise value | $343.47M |
| Price / sales | 59.84 |
| Price / book | 2.72 |
| Beta | 1.43 |
Trailing-twelve-month figures tagged in Abeona Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $5.82M |
|---|---|
| Net income (TTM) | -$62.89M |
| EPS (TTM) | -$1.11 |
| Operating margin | -1436.68% |
| Return on equity | -49.11% |
| Cash | $56.23M |
Range and volume for ABEO over the past 52 weeks.
| 52-week high | $7.65 |
|---|---|
| 52-week low | $4.00 |
| Volume | 880.2K |
| Average volume | 1.37M |
| Previous close | $5.96 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.